Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,676 | 330 | 96.5% |
| Education | $203.00 | 3 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $813.64 | 49 | $0 (2024) |
| Astellas Pharma US Inc | $606.79 | 25 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $554.52 | 33 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $474.03 | 31 | $0 (2024) |
| Merck Sharp & Dohme LLC | $425.34 | 27 | $0 (2022) |
| Amgen Inc. | $323.86 | 17 | $0 (2021) |
| Novo Nordisk Inc | $311.20 | 21 | $0 (2022) |
| PFIZER INC. | $295.68 | 16 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $287.03 | 13 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $240.64 | 15 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $527.26 | 32 | Novartis Pharmaceuticals Corporation ($165.50) |
| 2023 | $669.60 | 42 | ABBVIE INC. ($178.70) |
| 2022 | $709.28 | 35 | Novartis Pharmaceuticals Corporation ($204.89) |
| 2021 | $960.48 | 54 | AbbVie Inc. ($282.54) |
| 2020 | $585.14 | 39 | Novo Nordisk Inc ($109.29) |
| 2019 | $1,083 | 51 | Astellas Pharma US Inc ($326.95) |
| 2018 | $539.84 | 32 | Janssen Pharmaceuticals, Inc ($84.19) |
| 2017 | $803.54 | 48 | AstraZeneca Pharmaceuticals LP ($129.68) |
All Payment Transactions
333 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/21/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Hepatitis B Vaccine | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $32.64 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/08/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: VACCINES | ||||||
| 09/30/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: VACCINES | ||||||
| 09/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $32.64 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/09/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Oncology | ||||||
| 08/19/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.56 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: Respiratory | ||||||
| 06/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/10/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Respiratory | ||||||
| 05/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/14/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.72 | General |
| Category: NEUROSCIENCE | ||||||
| 05/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: NEUROSCIENCE | ||||||
| 04/15/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $3.15 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/02/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $8.92 | General |
| Category: NEUROSCIENCE | ||||||
| 03/27/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: Oncology | ||||||
| 03/20/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: NEUROSCIENCE | ||||||
| 03/11/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.90 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 39 | 7,280 | 8,727 | $1.2M | $276,389 |
| 2022 | 36 | 6,924 | 8,562 | $925,665 | $266,056 |
| 2021 | 41 | 7,270 | 8,927 | $901,862 | $283,280 |
| 2020 | 45 | 7,388 | 9,490 | $949,641 | $269,124 |
All Medicare Procedures & Services
161 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 472 | 472 | $290,295 | $70,319 | 24.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 360 | 531 | $220,235 | $57,910 | 26.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 232 | 332 | $97,180 | $24,571 | 25.3% |
| 82306 | Vitamin d-3 level | Office | 2023 | 500 | 527 | $59,885 | $15,288 | 25.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 47 | 47 | $51,345 | $13,243 | 25.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 543 | 692 | $52,345 | $11,360 | 21.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 570 | 812 | $35,530 | $8,401 | 23.6% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 521 | 555 | $38,850 | $8,205 | 21.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 525 | 618 | $38,490 | $8,105 | 21.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 98 | 98 | $27,440 | $7,429 | 27.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 565 | 840 | $27,375 | $7,039 | 25.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 500 | 553 | $84,890 | $6,854 | 8.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 556 | 740 | $24,980 | $5,630 | 22.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 24 | 24 | $18,960 | $4,587 | 24.2% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 193 | 205 | $17,425 | $3,694 | 21.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 99 | 99 | $9,230 | $3,562 | 38.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 21 | $12,030 | $3,317 | 27.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 302 | 328 | $15,700 | $3,128 | 19.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $13,475 | $3,106 | 23.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 16 | 16 | $12,640 | $3,051 | 24.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 49 | 49 | $4,655 | $1,763 | 37.9% |
| 84550 | Uric acid level, blood | Office | 2023 | 283 | 314 | $5,955 | $1,391 | 23.4% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 318 | 343 | $5,145 | $1,067 | 20.7% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 32 | 32 | $2,400 | $605.44 | 25.2% |
| 86803 | Hepatitis c antibody measurement | Office | 2023 | 31 | 32 | $1,755 | $433.38 | 24.7% |
About Dr. Michael Lowenthal, M.D
Dr. Michael Lowenthal, M.D is a Internal Medicine healthcare provider based in Great Neck, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1225031065.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Lowenthal, M.D has received a total of $5,879 in payments from pharmaceutical and medical device companies, with $527.26 received in 2024. These payments were reported across 333 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($5,676).
As a Medicare-enrolled provider, Lowenthal has provided services to 28,862 Medicare beneficiaries, totaling 35,706 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 161 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Great Neck, NY
- Active Since 05/24/2005
- Last Updated 04/04/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1225031065
Products in Payments
- UBRELVY (Drug) $512.92
- LEQVIO (Drug) $399.09
- FARXIGA (Drug) $343.31
- ELIQUIS (Drug) $317.24
- MYRBETRIQ (Drug) $271.42
- JARDIANCE (Drug) $231.65
- JANUVIA (Drug) $191.67
- Vascepa (Drug) $187.84
- NEXLETOL (Drug) $170.44
- XARELTO (Drug) $167.99
- ENTRESTO (Drug) $155.43
- SHINGRIX (Biological) $148.34
- Repatha (Biological) $138.09
- Ozempic (Drug) $131.33
- QULIPTA (Drug) $120.05
- Victoza (Drug) $115.02
- Cologuard Collection Kit (Device) $114.28
- Aimovig (Biological) $113.25
- Xofluza (Drug) $106.03
- PRALUENT ALIROCUMAB INJECTION (Biological) $93.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Great Neck
Dr. Jamie Hirsch, Md, MD
Internal Medicine — Payments: $69,165
Joanne Lee, M.d, M.D
Internal Medicine — Payments: $36,469
Bernard Rosof
Internal Medicine — Payments: $26,679
Dr. Shahram Shamekh, Md, MD
Internal Medicine — Payments: $18,187
Sanford Ratner, M.d, M.D
Internal Medicine — Payments: $16,933
David Edelson, Md, MD
Internal Medicine — Payments: $15,163